Saturday, December 19, 2015

Pembrolizumab Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1

cancer, gastric cancer, colorectal cancer, esophageal cancer, breast cancer, Hodgkin lymphoma, multiple myeloma and other tumors … of lung cancer than die of colon, breast, and prostate cancers combined. The two main types of lung cancer are non-small-cell …

No comments:

Post a Comment